Volitionrx Ltd (VNRX) · Insider trading
What Volitionrx's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$7,000
1 insider, 1 trade
Sold, 12 months
$0
0 insiders
Net, 12 months
+$7,000
bought less sold
Latest filing
2026-09-30
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Reynolds Cameron JohnDirector, President and CEO | $318,867 | – | 8 | 2025-11-17 | 2,554,847 |
| Innes Guy ArchibaldDirector | $309,453 | – | 5 | 2025-10-14 | 1,062,967 |
| Still Timothy IDirector | $74,326 | – | 2 | 2025-10-14 | 1,535,458 |
| Micallef Jacob VincentChief Scientific Officer | $46,404 | – | 2 | 2025-05-19 | 426,033 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2025-11-17 | Reynolds Cameron JohnDirector, President and CEO | Buy | 20,000 | 0.35 | $7,000 | 2,554,847 | Form 4 |
| 2025-10-14 | Still Timothy IDirector | Buy | 48,076 | 0.51 | $24,519 | 1,535,458 | Form 4 |
| 2025-10-14 | Innes Guy ArchibaldDirector | Buy | 96,153 | 0.51 | $49,038 | 1,062,967 | Form 4 |
| 2025-10-14 | Reynolds Cameron JohnDirector, President and CEO | Buy | 110,000 | 0.51 | $56,100 | 2,534,847 | Form 4 |
| 2025-09-12 | Reynolds Cameron JohnDirector, President and CEO | Buy | 15,000 | 0.66 | $9,900 | 2,624,847 | Form 4 |
| 2025-08-05 | Reynolds Cameron JohnDirector, President and CEO | Buy | 78,125 | 0.64 | $50,000 | 2,609,847 | Form 4 |
| 2025-08-05 | Innes Guy ArchibaldDirector | Buy | 78,125 | 0.64 | $50,000 | 966,814 | Form 4 |
| 2025-06-12 | Reynolds Cameron JohnDirector, President and CEO | Buy | 12,500 | 0.59 | $7,375 | 2,331,722 | Form 4 |
| 2025-06-03 | Innes Guy ArchibaldDirector | Buy | 20,000 | 0.54 | $10,800 | 888,689 | Form 4 |
| 2025-05-19 | Reynolds Cameron JohnDirector, President and CEO | Buy | 20,000 | 0.44 | $8,800 | 2,319,222 | Form 4 |
| 2025-05-19 | Micallef Jacob VincentChief Scientific Officer | Buy | 50,000 | 0.43 | $21,500 | 426,033 | Form 4 |
| 2025-03-26 | Innes Guy ArchibaldDirector | Buy | 181,818 | 0.55 | $100,000 | 868,689 | Form 4 |
| 2025-03-26 | Reynolds Cameron JohnDirector, President and CEO | Buy | 181,818 | 0.55 | $100,000 | 2,299,222 | Form 4 |
| 2024-12-09 | Reynolds Cameron JohnDirector, President and CEO | Buy | 139,811 | 0.57 | $79,692 | 2,117,404 | Form 4 |
| 2024-12-09 | Micallef Jacob VincentChief Scientific Officer | Buy | 43,691 | 0.57 | $24,904 | 394,352 | Form 4 |
| 2024-12-09 | Still Timothy IDirector | Buy | 87,382 | 0.57 | $49,808 | 1,487,382 | Form 4 |
| 2024-12-09 | Innes Guy ArchibaldDirector | Buy | 174,764 | 0.57 | $99,615 | 617,085 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
76 × grant or award54 × shares withheld for tax
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-28 | Michel GaetanChief Operating Officer | Shares withheld for tax F | −608 | 0.25 | 12,232 | Form 4 |
| 2026-09-28 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −284 | 0.25 | 16,284 | Form 4 |
| 2026-03-17 | Micallef Jacob VincentChief Scientific Officer | Shares withheld for tax F | −5,310 | 0.19 | 572,179 | Form 4 |
| 2026-03-17 | Plummer NicholasGC - Volition Diagnostics | Shares withheld for tax F | −7,003 | 0.19 | 407,267 | Form 4 |
| 2026-03-17 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −3,948 | 0.19 | 273,993 | Form 4 |
| 2026-03-17 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −5,251 | 0.19 | 331,338 | Form 4 |
| 2026-03-01 | Plummer NicholasGC - Volition Diagnostics | Shares withheld for tax F | −5,867 | 0.21 | 414,270 | Form 4 |
| 2026-03-01 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −2,283 | 0.21 | 336,589 | Form 4 |
| 2026-03-01 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −3,321 | 0.21 | 277,941 | Form 4 |
| 2026-02-26 | Innes Guy ArchibaldDirector | Grant or award A | +178,000 | – | 1,252,967 | Form 4 |
| 2026-02-26 | Micallef Jacob VincentChief Scientific Officer | Grant or award A | +149,000 | – | 577,489 | Form 4 |
| 2026-02-26 | Kway JasmineCEO - Singapore Volition | Grant or award A | +173,000 | – | 418,614 | Form 4 |
| 2026-02-26 | Nguyen KimDirector | Grant or award A | +178,000 | – | 305,816 | Form 4 |
| 2026-02-26 | Plummer NicholasGC - Volition Diagnostics | Grant or award A | +187,000 | – | 420,137 | Form 4 |
| 2026-02-26 | Rootsaert Rodney GerardSecretary | Grant or award A | +119,000 | – | 281,262 | Form 4 |
| 2026-02-26 | Hughes TerigChief Financial Officer | Grant or award A | +202,000 | – | 684,970 | Form 4 |
| 2026-02-26 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Grant or award A | +142,000 | – | 324,072 | Form 4 |
| 2026-02-26 | Reynolds Cameron JohnDirector, President and CEO | Grant or award A | +486,000 | – | 3,115,547 | Form 4 |
| 2026-02-26 | Rubin EthelDirector | Grant or award A | +178,000 | – | 252,948 | Form 4 |
| 2026-02-26 | Forterre GaelChief Commercial Officer | Grant or award A | +149,000 | – | 338,872 | Form 4 |
| 2026-02-01 | Plummer NicholasGC - Volition Diagnostics | Shares withheld for tax F | −5,647 | 0.29 | 233,137 | Form 4 |
| 2026-02-01 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −3,196 | 0.29 | 162,262 | Form 4 |
| 2026-02-01 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −2,010 | 0.29 | 189,872 | Form 4 |
| 2026-01-22 | Kway JasmineCEO - Singapore Volition | Grant or award A | +42,000 | – | 245,614 | Form 4 |
| 2026-01-22 | Nguyen KimDirector | Grant or award A | +12,000 | – | 127,816 | Form 4 |
| 2026-01-22 | Henshall MickieDirector | Grant or award A | +12,000 | – | 44,206 | Form 4 |
| 2026-01-22 | Plummer NicholasGC - Volition Diagnostics | Grant or award A | +44,700 | – | 238,784 | Form 4 |
| 2026-01-22 | Micallef Jacob VincentChief Scientific Officer | Grant or award A | +35,400 | – | 428,489 | Form 4 |
| 2026-01-22 | Rootsaert Rodney GerardSecretary | Grant or award A | +28,200 | – | 165,458 | Form 4 |
| 2026-01-22 | Butera Salvatore ThomasCEO - Volition Veterinary | Grant or award A | +53,400 | – | 375,203 | Form 4 |
| 2026-01-22 | Barnes PhillipDirector | Grant or award A | +12,000 | – | 67,368 | Form 4 |
| 2026-01-22 | Hughes TerigChief Financial Officer | Grant or award A | +49,200 | – | 482,970 | Form 4 |
| 2026-01-22 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Grant or award A | +33,900 | – | 182,072 | Form 4 |
| 2026-01-22 | Still Timothy IDirector | Grant or award A | +90,000 | – | 1,625,458 | Form 4 |
| 2026-01-22 | Colman AlanDirector | Grant or award A | +12,000 | – | 257,364 | Form 4 |
| 2026-01-22 | Reynolds Cameron JohnDirector, President and CEO | Grant or award A | +74,700 | – | 2,629,547 | Form 4 |
| 2026-01-22 | Forterre GaelChief Commercial Officer | Grant or award A | +38,100 | – | 191,882 | Form 4 |
| 2026-01-22 | Innes Guy ArchibaldDirector | Grant or award A | +12,000 | – | 1,074,967 | Form 4 |
| 2026-01-22 | Rubin EthelDirector | Grant or award A | +12,000 | – | 74,948 | Form 4 |
| 2025-11-01 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −1,753 | 0.43 | 153,782 | Form 4 |
| 2025-11-01 | Butera Salvatore ThomasCEO - Volition Veterinary | Shares withheld for tax F | −4,648 | 0.43 | 321,803 | Form 4 |
| 2025-11-01 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −3,197 | 0.43 | 137,258 | Form 4 |
| 2025-11-01 | Plummer NicholasGC - Volition Diagnostics | Shares withheld for tax F | −5,647 | 0.43 | 194,084 | Form 4 |
| 2025-11-01 | Retter AndrewChief Medical Officer | Shares withheld for tax F | −4,588 | 0.43 | 146,568 | Form 4 |
| 2025-10-04 | Micallef Jacob VincentChief Scientific Officer | Shares withheld for tax F | −5,850 | 0.65 | 393,089 | Form 4 |
| 2025-10-04 | Michel GaetanChief Operating Officer | Shares withheld for tax F | −12,333 | 0.65 | 256,746 | Form 4 |
| 2025-10-04 | Plummer NicholasGC - Volition Diagnostics | Shares withheld for tax F | −8,146 | 0.65 | 199,731 | Form 4 |
| 2025-10-04 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −5,389 | 0.65 | 155,535 | Form 4 |
| 2025-10-04 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −4,620 | 0.65 | 140,455 | Form 4 |
| 2025-10-04 | Butera Salvatore ThomasCEO - Volition Veterinary | Shares withheld for tax F | −5,834 | 0.65 | 326,451 | Form 4 |
| 2025-10-04 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Shares withheld for tax F | −6,110 | 0.65 | 148,172 | Form 4 |
| 2025-09-28 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −5,503 | 0.61 | 160,924 | Form 4 |
| 2025-09-28 | Michel GaetanChief Operating Officer | Shares withheld for tax F | −11,362 | 0.61 | 369,079 | Form 4 |
| 2025-09-28 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Shares withheld for tax F | −5,604 | 0.61 | 154,282 | Form 4 |
| 2025-09-28 | Micallef Jacob VincentChief Scientific Officer | Shares withheld for tax F | −5,568 | 0.61 | 398,939 | Form 4 |
| 2025-09-28 | Butera Salvatore ThomasCEO - Volition Veterinary | Shares withheld for tax F | −5,230 | 0.61 | 332,285 | Form 4 |
| 2025-09-28 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −4,158 | 0.61 | 145,075 | Form 4 |
| 2025-08-15 | Forterre GaelChief Commercial Officer | Grant or award A | +9,727 | – | 166,427 | Form 4 |
| 2025-08-15 | Kway JasmineCEO - Singapore Volition | Grant or award A | +12,507 | – | 203,614 | Form 4 |
| 2025-08-15 | Nguyen KimDirector | Grant or award A | +17,424 | – | 115,816 | Form 4 |
| 2025-08-15 | Rubin EthelDirector | Grant or award A | +17,424 | – | 62,948 | Form 4 |
| 2025-08-15 | Plummer NicholasGC - Volition Diagnostics | Grant or award A | +24,031 | – | 207,877 | Form 4 |
| 2025-08-15 | Retter AndrewChief Medical Officer | Grant or award A | +19,524 | – | 151,156 | Form 4 |
| 2025-08-15 | Butera Salvatore ThomasCEO - Volition Veterinary | Grant or award A | +33,991 | – | 337,515 | Form 4 |
| 2025-08-15 | Rootsaert Rodney GerardSecretary | Grant or award A | +15,223 | – | 149,233 | Form 4 |
| 2025-08-15 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Grant or award A | +27,400 | – | 159,886 | Form 4 |
| 2025-08-15 | Hughes TerigChief Financial Officer | Grant or award A | +26,143 | – | 533,770 | Form 4 |
| 2025-08-01 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −4,279 | 0.64 | 134,010 | Form 4 |
| 2025-08-01 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −2,766 | 0.64 | 156,700 | Form 4 |
| 2025-08-01 | Plummer NicholasGC - Volition Diagnostics | Shares withheld for tax F | −4,451 | 0.64 | 183,846 | Form 4 |
| 2025-08-01 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Shares withheld for tax F | −8,620 | 0.64 | 132,486 | Form 4 |
| 2025-08-01 | Retter AndrewChief Medical Officer | Shares withheld for tax F | −6,142 | 0.64 | 131,632 | Form 4 |
| 2025-08-01 | Butera Salvatore ThomasCEO - Volition Veterinary | Shares withheld for tax F | −6,393 | 0.64 | 303,524 | Form 4 |
| 2025-07-24 | Reynolds Cameron JohnDirector, President and CEO | Grant or award A | +200,000 | – | 2,531,722 | Form 4 |
| 2025-07-24 | Hughes TerigChief Financial Officer | Grant or award A | +100,000 | – | 507,627 | Form 4 |
| 2025-07-01 | Retter AndrewChief Medical Officer | Shares withheld for tax F | −4,401 | 0.77 | 137,774 | Form 4 |
| 2025-07-01 | Butera Salvatore ThomasCEO - Volition Veterinary | Shares withheld for tax F | −4,462 | 0.77 | 309,917 | Form 4 |
| 2025-07-01 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Shares withheld for tax F | −6,177 | 0.77 | 141,106 | Form 4 |
| 2025-07-01 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −3,066 | 0.77 | 138,289 | Form 4 |
| 2025-07-01 | Plummer NicholasGC - Volition Diagnostics | Shares withheld for tax F | −5,417 | 0.77 | 188,297 | Form 4 |
| 2025-06-01 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −1,996 | 0.77 | 159,466 | Form 4 |
| 2025-06-01 | Rubin EthelDirector | Grant or award A | +11,983 | – | 45,524 | Form 4 |
| 2025-06-01 | Micallef Jacob VincentChief Scientific Officer | Shares withheld for tax F | −21,526 | 0.50 | 404,507 | Form 4 |
| 2025-06-01 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Grant or award A | +18,341 | – | 147,283 | Form 4 |
| 2025-06-01 | Hughes TerigChief Financial Officer | Grant or award A | +17,406 | – | 407,627 | Form 4 |
| 2025-06-01 | Retter AndrewChief Medical Officer | Grant or award A | +13,069 | – | 146,773 | Form 4 |
| 2025-06-01 | Retter AndrewChief Medical Officer | Shares withheld for tax F | −4,598 | 0.50 | 142,175 | Form 4 |
| 2025-06-01 | Forterre GaelChief Commercial Officer | Grant or award A | +6,690 | – | 165,696 | Form 4 |
| 2025-06-01 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −4,234 | 0.50 | 161,462 | Form 4 |
| 2025-06-01 | Rootsaert Rodney GerardSecretary | Grant or award A | +10,190 | – | 147,763 | Form 4 |
| 2025-06-01 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −6,408 | 0.50 | 141,355 | Form 4 |
| 2025-06-01 | Butera Salvatore ThomasCEO, Volition Veterinary | Grant or award A | +23,377 | – | 326,062 | Form 4 |
| 2025-06-01 | Butera Salvatore ThomasCEO, Volition Veterinary | Shares withheld for tax F | −11,683 | 0.50 | 314,379 | Form 4 |
| 2025-06-01 | Michel GaetanChief Operating Officer | Shares withheld for tax F | −7,835 | 0.50 | 380,441 | Form 4 |
| 2025-06-01 | Plummer NicholasGC, Volition Diagnostics | Grant or award A | +16,086 | – | 193,714 | Form 4 |
| 2025-06-01 | Nguyen KimDirector | Grant or award A | +11,983 | – | 98,392 | Form 4 |
| 2025-06-01 | Kway JasmineCEO - Singapore Volition | Grant or award A | +8,327 | – | 191,107 | Form 4 |
| 2025-05-01 | Micallef Jacob VincentChief Scientific Officer | Shares withheld for tax F | −18,319 | 0.49 | 376,033 | Form 4 |
| 2025-05-01 | Forterre GaelChief Commercial Officer | Shares withheld for tax F | −3,698 | 0.49 | 159,006 | Form 4 |
| 2025-05-01 | Butera Salvatore ThomasCEO, Volition Veterinary | Shares withheld for tax F | −10,205 | 0.49 | 302,685 | Form 4 |
| 2025-05-01 | Rootsaert Rodney GerardSecretary | Shares withheld for tax F | −5,453 | 0.49 | 137,573 | Form 4 |
| 2025-05-01 | Retter AndrewChief Medical Officer | Shares withheld for tax F | −3,913 | 0.49 | 133,704 | Form 4 |
| 2025-05-01 | Michel GaetanChief Operating Officer | Shares withheld for tax F | −6,844 | 0.49 | 388,276 | Form 4 |
| 2025-03-01 | Hughes TerigChief Financial Officer | Grant or award A | +13,969 | – | 390,221 | Form 4 |
| 2025-03-01 | Innes Guy ArchibaldDirector | Grant or award A | +19,786 | – | 686,871 | Form 4 |
| 2025-03-01 | Forterre GaelChief Commercial Officer | Grant or award A | +5,523 | – | 162,704 | Form 4 |
| 2025-03-01 | Butera Salvatore ThomasCEO - Volition Veterinary | Grant or award A | +19,300 | – | 312,890 | Form 4 |
| 2025-03-01 | Rubin EthelDirector | Grant or award A | +9,893 | – | 33,541 | Form 4 |
| 2025-03-01 | Retter AndrewChief Medical Officer | Grant or award A | +10,142 | – | 137,617 | Form 4 |
| 2025-03-01 | Kway JasmineCEO - Singapore Volition | Grant or award A | +16,708 | – | 182,780 | Form 4 |
| 2025-03-01 | Colman AlanDirector | Grant or award A | +14,840 | – | 245,364 | Form 4 |
| 2025-03-01 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Grant or award A | +14,233 | – | 128,942 | Form 4 |
| 2025-03-01 | Nguyen KimDirector | Grant or award A | +9,893 | – | 86,409 | Form 4 |
| 2025-03-01 | Plummer NicholasGC - Volition Diagnostics | Grant or award A | +12,483 | – | 177,628 | Form 4 |
| 2025-03-01 | Rootsaert Rodney GerardSecretary | Grant or award A | +7,908 | – | 143,026 | Form 4 |
| 2025-01-15 | Innes Guy ArchibaldDirector | Grant or award A | +50,000 | – | 667,085 | Form 4 |
| 2024-12-01 | Butera Salvatore ThomasCEO, Volition Veterinary | Grant or award A | +16,871 | – | 293,590 | Form 4 |
| 2024-12-01 | Retter AndrewChief Medical Officer | Grant or award A | +9,365 | – | 127,475 | Form 4 |
| 2024-12-01 | Hughes TerigChief Financial Officer | Grant or award A | +12,683 | – | 376,252 | Form 4 |
| 2024-12-01 | Nguyen KimDirector | Grant or award A | +8,648 | – | 76,516 | Form 4 |
| 2024-12-01 | Batchelor Ann-LouiseGroup Chief Marketing Officer | Grant or award A | +13,143 | – | 114,709 | Form 4 |
| 2024-12-01 | Colman AlanDirector | Grant or award A | +12,972 | – | 230,524 | Form 4 |
| 2024-12-01 | Kway JasmineCEO, Singapore Volition | Grant or award A | +15,169 | – | 166,072 | Form 4 |
| 2024-12-01 | Rubin EthelDirector | Grant or award A | +8,648 | – | 23,648 | Form 4 |
| 2024-12-01 | Forterre GaelChief Commercial Officer | Grant or award A | +4,828 | – | 157,181 | Form 4 |
| 2024-12-01 | Innes Guy ArchibaldDirector | Grant or award A | +17,296 | – | 442,321 | Form 4 |
| 2024-12-01 | Plummer NicholasGC, Volition Diagnostics | Grant or award A | +11,527 | – | 165,145 | Form 4 |
| 2024-12-01 | Rootsaert Rodney GerardSecretary | Grant or award A | +7,302 | – | 135,118 | Form 4 |
| 2024-11-06 | Still Timothy IDirector | Grant or award A | +400,000 | – | 400,000 | Form 4 |
| 2024-11-06 | Still Timothy IDirector | Grant or award A | +1,000,000 | – | 1,400,000 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.